Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The main aim of this study is to test the safety of acadesine in patients with B-CLL and see
what effects it has on patients and their leukaemia. The study also aims to examine the way
acadesine is processed by the body. The study will look at the effects of acadesine in the
body and the concentration of the drug and its main by-product (ZMP) in the blood to
determine the dose and the frequency of dosing that is likely to be the most effective.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Advancell - Advanced In Vitro Cell Technologies, S.A.